Stay informed with the latest developments in psychedelic medicine and research
Found 50 articles
Vote! Who should be Maps Credit Union girls Athlete of the Week? Statesman Journal
Vote! Who should be Maps Credit Union boys Athlete of the Week? Statesman Journal
Ex-British army chief calls on ministers to back MDMA-assisted therapy for veterans The Guardian
Medical marijuana could soon be reclassified into a medical category that includes prescription drugs like Tylenol with codeine, ketamine and anabolic steroids.
Researchers found that a single dose of psilocybin alters the electrical properties of brain cells for months. This functional plasticity, rather than structural growth, may explain why psychedelic therapy offers enduring relief from depression.
First-of-its-kind clinical guidance on psychedelic medicine released News-Medical
Understanding the Future of Psychedelic Therapy in Texas Texas Monthly
Preparation Improves Psychedelic Therapy for MDD, With Gianluca Florineth, MSc HCPLive
After publishing a new study investigating synthetic analogs for iboga molecules, scientist and co-founder of Gilgamesh Pharmaceuticals, Dalibor Sames, decided to take the compound he has described as an intelligent molecular machine. The post New Theories and Findings From The Frontier of Ibogaine Research first appeared on Lucid News. The post New Theories and Findings From The Frontier of Ibogaine Research appeared first on Lucid News.
Psychedelic therapy gains ground in Europe, under strict conditions RFI
A comprehensive analysis maps where physical shrinkage and electrical dysfunction converge in the depressed brain, linking these overlapping abnormalities to genes involved in early neural development.
New Hampshire Lawmakers Approve Bipartisan Bill To Legalize Psilocybin For Medical Use, While Rejecting Separate Psychedelics Measure Marijuana Moment
Scientists have linked the subjective intensity of ibogaine trips to tangible recovery in veterans. Those who felt a sense of unity and sacredness showed larger drops in trauma symptoms and slower brain wave frequencies one month later.
CDMO Vetter maps out expansion in Germany with €480M for new plant Fierce Pharma
Healing Hearts awards over half a million for end-of-life psychedelic therapy Mugglehead Magazine
A state-by-state and federal review of psychedelics-related bills introduced or advanced in January 2026, including pilot programs, trigger laws, and research programs.
magic mushrooms long covid treatment psilocybin Infectious Disease Special Edition
How much snow will North Carolina get? Maps show up to 15 inches The Asheville Citizen Times
McNary hoops player wins Maps Credit Union boys Athlete of the Week Statesman Journal
What Role Does Ketamine-Assisted Psychotherapy Play in Depression Care? Vocal
New maps show the most detailed demographic data for every S.F. neighborhood San Francisco Chronicle
Maps: Pittsburgh has more decaying homes than it can demolish Pittsburgh's Public Source
Draft Alachua County school boundary maps to be presented at several public meetings WCJB
Maps show where power is being restored in Nashville amid claims prioritization is being decided by race, income WSMV
The psychedelic medicine revolution that wasn’t Politico
Northwell opens psychedelic research center for mental health Long Island Business News
Article | The psychedelic medicine revolution that wasn’t POLITICO Pro
Exploring psychedelic therapy for depression, anxiety and PTSD PIX11
Psychedelic Medicine Guidance Released by Johns Hopkins Medicine and Unbound Medicine | Newswise Newswise
Dr. Joost Breeksema is a Dutch researcher, philosopher, and postdoctoral fellow in the Department of Psychiatry at University Medical Center Groningen (UMCG). He also serves as the Executive Director of the OPEN Foundation, a non-profit based in Amsterdam that has been advancing interdisciplinary psychedelic research since 2007 and runs the popular ICPR conference. (The next […]
“Changes Are Never Linear”: Joost Breeksema on the Human Side of Psychedelic Therapy Psychedelic Alpha
Your one-stop digest for the latest coverage of psychedelics business, policy, research and beyond, for the week commencing January 19, 2025.
‘We are approaching a watershed moment for psychedelic health care with ‘magic mushroom’ psilocybin the star’ Genetic Literacy Project
The overlooked middle ground between microdosing and macrodosing. Psychology Today
The overlooked middle ground between microdosing and macrodosing. Psychology Today
The Untold Story of Women Psychedelic Therapists: 5 Questions with historian Zoë Dubus The Microdose | Substack
Serenity Mental Health Centers Offers Breakthrough Ketamine Therapy in Las Vegas Business Wire
Missi Wooldridge, Heather Kuiper, Doris Payer, and Logina Mostafa argue that public health has been largely missing from this rapidly evolving landscape, and that 2025 marked an inflection point for “psychedelic public health” as an emerging field.
New ketamine therapy clinic opens in Union County Central New Jersey News
The passage of New Jersey Assembly Bill 3852, which creates a psilocybin therapy pilot program, exposed deep rifts between advocates seeking a medicalized pharmaceutical-led model and those supporting a community-based framework to regulate less costly psilocybin mushrooms. The post NJ Psilocybin Legislation Exposes Conflicts Between Advocates for Different Therapeutic Models first appeared on Lucid News. The post NJ Psilocybin Legislation Exposes Conflicts Between Advocates for Different Thera
New Jersey passes a bill opening the door to legal psychedelic therapy. Psychology Today
Fireside Project is a nonprofit that helps reduce the risks of psychedelic experiences through a free support line, coaching, education, and research. In this episode, Joshua White speaks with Psychedelics Today about why real-time support matters, what it takes to run a national hotline, and what Fireside learned after more than 30,000 conversations since launch. […] The post Joshua White – Fireside Project and Lucy, an AI Training Simulator for Psychedelic Support appeared first on Psychedelic
FDA’s Farchione Says Psychedelic INDs Now “a Third” of Her Workload; NIDA’s Volkow Questions Schedule I Placement • Ipsos/Psychedelic Alpha Poll Probes Americans’ Attitudes Towards Psychedelics • RAND Estimates 10 Million U.S. Adults Microdosed Last Year • Reunion Targets Single Phase 3 Path in PPD; Releases Additional Phase 2 Data • MindMed Rebrands to Definium, Launches LSD Education Push • Interview: Independent Psychedelic Evidence Assessment Working Group • New Jersey Governor S
Recreational psilocybin differs from research-based use and holds major risks. Psychology Today
A third of Oregon’s licensed psilocybin service centers have closed, NYT reporting finds Oregon Public Broadcasting - OPB
Why Was the Acid Drug or LSD Created? Verywell Mind
NJ becomes latest state to legalize medical ‘Magic Mushroom’ therapy News12 | New Jersey
What S2283 Actually Does — and Why It Is a Research Pilot, Not Legalization In January 2026, the New Jersey Legislature passed Senate Bill S2283, formally titled the Psilocybin Behavioral Health Access and Services Act. On January 20, 2026, shortly before leaving office, Governor Phil Murphy signed the bill into law. Despite widespread media coverage […] The post Did New Jersey Really Just Legalize Psilocybin? appeared first on Psychedelics Today.
New Jersey Governor Signs Psilocybin Therapy Bill Into Law, Advancing Evidence-Based Treatment Options for Mental Health PRWeb
New Jersey Governor Signs Bill Creating Psilocybin Therapy Pilot Program And Allocating $6 Million To Psychedelic Treatment Effort Marijuana Moment